It can be used up to 10% worldwide except for the US and Canada
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
Understanding how fast tirzepatide works and how long it takes to see results helps set realistic expectations during the adjustment period
Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, and Trulicity Linked to Gastroparesis and Stomach Paralysis There are legal actions being taken for gastroparesis/stomach paralysis after use of diabetic drugs Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, and Trulicity for weight loss
